ArticleSensors (Basel, Switzerland)2026
Matrix Effects on the Quantification of NanoLuc Bioluminescence in Ex Vivo Organ Homogenates.
Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Bioluminescent reporters and biosensors are widely used to quantify gene expression, evaluate delivery systems and assess biodistribution because they provide low-background readouts over a broad dynamic range. The NanoLuc-furimazine system is particularly attractive owing to its high brightness and stability. Ex vivo analysis of organ homogenates offers a controlled approach for measuring tissue-associated reporter activity, yet matrix-dependent effects are often overlooked in quantitative interpretation. Here, we systematically evaluated how mouse organ homogenates affect NanoLuc-furimazine measurements by spiking defined amounts of purified NanoLuc into different organ matrices. Across matrices, optical profiles, blank signals, calibration slopes, and estimated limits of detection and quantification varied, resulting in substantial differences in the measured NanoLuc signal. Further analysis showed that NanoLuc-independent furimazine luminescence arises from lysis-buffer components and protein-containing environments. Matrix-matched blank subtraction reduced background-related bias, whereas matrix-specific calibration demonstrated differences in analytical response, particularly for weak signals and optically dense samples. These findings highlight the extent of matrix-dependent variability in ex vivo NanoLuc measurements and support more accurate interpretation of reporter signals in delivery, biodistribution, biosensing, and gene-expression studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.